Sheeba Mathew
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- Stress Responses and Cortisol
Papers in
-
- CRISPR and Genetic Engineering 1
- Chromatin Remodeling and Cancer 1
- Advanced biosensing and bioanalysis techniques 1
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- Joseph Vallone (3 shared papers)Venkat Subramaniam (3 shared papers)Eric S. Silverman (3 shared papers)Scott T. Weiss (2 shared papers)Stephanie A. Shore (2 shared papers)Débora S. Faffe (1 shared paper)Benjamin A. Raby (1 shared paper)Lyle J. Palmer (1 shared paper)
- Journals
- Nature Communications (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)Retrovirology (1 paper)Transfusion (1 paper)PLoS Pathogens (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Sheeba Mathew
8 papers receiving 368 citations
Peers
Comparison fields: 5 of 68
- Virology 50
- Behavioral Neuroscience 21
- Physiology 92
- Immunology 61
- Infectious Diseases 45
Countries citing papers authored by Sheeba Mathew
This map shows the geographic impact of Sheeba Mathew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheeba Mathew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheeba Mathew more than expected).
Fields of papers citing papers by Sheeba Mathew
This network shows the impact of papers produced by Sheeba Mathew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheeba Mathew. The network helps show where Sheeba Mathew may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheeba Mathew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 210 | |
| 2 | 2009 | 51 | |
| 3 | 2004 | 50 | |
| 4 | 2004 | 22 | |
| 5 | 2013 | 14 | |
| 6 | 2021 | 13 | |
| 7 | 2005 | 9 | |
| 8 | 2022 | 5 |
About Sheeba Mathew
Sheeba Mathew is a scholar working on Molecular Biology, Infectious Diseases, Virology, Pulmonary and Respiratory Medicine and Clinical Psychology, having authored 8 papers that have together received 374 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (2 papers), HIV Research and Treatment (2 papers), Family Caregiving in Mental Illness (1 paper), CRISPR and Genetic Engineering (1 paper), Pulmonary Hypertension Research and Treatments (1 paper), Chromatin Remodeling and Cancer (1 paper), Asthma and respiratory diseases (1 paper) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Virology (50 citations), Behavioral Neuroscience (21 citations), Physiology (92 citations), Immunology (61 citations) and Infectious Diseases (45 citations). Sheeba Mathew has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Joseph Vallone, Venkat Subramaniam, Eric S. Silverman, Scott T. Weiss, Stephanie A. Shore, Débora S. Faffe, Benjamin A. Raby, Lyle J. Palmer, Ganjam V. Kalpana and Xuhong Wu. Their work appears in journals such as Nature Communications, American Journal of Respiratory and Critical Care Medicine, Retrovirology, Transfusion and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.